$TCDA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tricida, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Tricida, Inc.. Get notifications about new insider transactions in Tricida, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 05 2019 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 37.07 | 3,371 | 124,963 | 659,048 | 662.4 K to 659 K (-0.51 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Gift | G | 0.00 | 7,500 | 0 | 661,340 | 668.8 K to 661.3 K (-1.12 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 3,100 | 2,480 | 8,800 | |
| Jul 05 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 36.91 | 3,000 | 110,730 | 60,344 | 63.3 K to 60.3 K (-4.74 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 36.89 | 3,008 | 110,965 | 60,336 | 63.3 K to 60.3 K (-4.75 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 36.91 | 3,100 | 114,421 | 41,315 | 44.4 K to 41.3 K (-6.98 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 3,100 | 2,480 | 44,415 | 41.3 K to 44.4 K (+7.50 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Option Exercise | M | 0.72 | 3,000 | 2,160 | 11,100 | |
| Jul 05 2019 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Sell | S | 36.91 | 3,000 | 110,730 | 14,806 | 17.8 K to 14.8 K (-16.85 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Buy | M | 0.72 | 3,000 | 2,160 | 17,806 | 14.8 K to 17.8 K (+20.26 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 1.68 | 5,950 | 9,996 | 34,251 | |
| Jul 05 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 1.68 | 6,281 | 10,552 | 3,769 | |
| Jul 05 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 2,769 | 2,215 | 2,355 | |
| Jul 05 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 37.04 | 15,407 | 570,675 | 0 | 15.4 K to 0 (-100.00 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 1.68 | 5,950 | 9,996 | 15,000 | 9.1 K to 15 K (+65.75 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 1.68 | 6,281 | 10,552 | 9,050 | 2.8 K to 9.1 K (+226.83 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 2,769 | 2,215 | 2,769 | 0 to 2.8 K |
| Jul 05 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 40,000 | 32,000 | 60,307 | |
| Jul 05 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 37.10 | 40,401 | 1,498,877 | 0 | 40.4 K to 0 (-100.00 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 40,000 | 32,000 | 40,000 | 0 to 40 K |
| Jul 05 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 37.03 | 4,000 | 148,120 | 11,725 | 15.7 K to 11.7 K (-25.44 %) |
| Jul 05 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 37.05 | 3,000 | 111,150 | 164,390 | 167.4 K to 164.4 K (-1.79 %) |
| Jun 04 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | A | 36.74 | 7,068 | 259,678 | 7,068 | |
| Jun 04 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Grant | A | 0.00 | 1,879 | 0 | 41,315 | 39.4 K to 41.3 K (+4.76 %) |
| Jun 04 2019 | TCDA | Tricida, Inc. | Hirsch David | Director | Option Exercise | A | 36.74 | 7,068 | 259,678 | 7,068 | |
| Jun 04 2019 | TCDA | Tricida, Inc. | Hirsch David | Director | Grant | A | 0.00 | 1,879 | 0 | 5,511 | 3.6 K to 5.5 K (+51.73 %) |
| Jun 04 2019 | TCDA | Tricida, Inc. | FALBERG KATHRYN E | Director | Option Exercise | A | 36.74 | 7,068 | 259,678 | 7,068 | |
| Jun 04 2019 | TCDA | Tricida, Inc. | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 1,879 | 0 | 37,090 | 35.2 K to 37.1 K (+5.34 %) |
| Jun 04 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Option Exercise | A | 36.74 | 7,068 | 259,678 | 7,068 | |
| Jun 04 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Grant | A | 0.00 | 1,879 | 0 | 219,078 | 217.2 K to 219.1 K (+0.87 %) |
| Jun 04 2019 | TCDA | Tricida, Inc. | Bonita David P | Director | Option Exercise | A | 36.74 | 7,068 | 259,678 | 7,068 | |
| Jun 04 2019 | TCDA | Tricida, Inc. | Bonita David P | Director | Grant | A | 0.00 | 1,879 | 0 | 5,511 | 3.6 K to 5.5 K (+51.73 %) |
| Jun 04 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Option Exercise | A | 36.74 | 7,068 | 259,678 | 7,068 | |
| Jun 04 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 1,879 | 0 | 167,390 | 165.5 K to 167.4 K (+1.14 %) |
| Apr 08 2019 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Grant | A | 36.00 | 20,000 | 720,000 | 25,000 | 5 K to 25 K (+400.00 %) |
| Apr 05 2019 | TCDA | Tricida, Inc. | Bonita David P | Director | Buy | P | 36.00 | 225,000 | 8,100,000 | 11,114,280 | 10.9 M to 11.1 M (+2.07 %) |
| Apr 05 2019 | TCDA | Tricida, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 36.00 | 225,000 | 8,100,000 | 11,114,280 | 10.9 M to 11.1 M (+2.07 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 22,100 | 17,680 | 11,900 | |
| Mar 29 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 34.18 | 22,100 | 755,378 | 63,344 | 85.4 K to 63.3 K (-25.86 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 34.19 | 22,100 | 755,599 | 63,344 | 85.4 K to 63.3 K (-25.86 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 34.19 | 22,100 | 755,599 | 39,436 | 61.5 K to 39.4 K (-35.91 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 22,100 | 17,680 | 61,536 | 39.4 K to 61.5 K (+56.04 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Option Exercise | M | 0.72 | 6,000 | 4,320 | 14,100 | |
| Mar 29 2019 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Sell | S | 29.99 | 6,000 | 179,940 | 13,832 | 19.8 K to 13.8 K (-30.25 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Buy | M | 0.72 | 6,000 | 4,320 | 19,832 | 13.8 K to 19.8 K (+43.38 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 7,438 | 5,950 | 5,124 | |
| Mar 29 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 8,062 | 6,450 | 0 | |
| Mar 29 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 30.74 | 15,500 | 476,470 | 0 | 15.5 K to 0 (-100.00 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 7,438 | 5,950 | 15,500 | 8.1 K to 15.5 K (+92.26 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 8,062 | 6,450 | 8,062 | 0 to 8.1 K |
| Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 1.68 | 27,856 | 46,798 | 23,576 | |
| Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 1.68 | 13,919 | 23,384 | 9,950 | |
| Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 2.39 | 8,165 | 19,514 | 21,985 | |
| Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 2,985 | 2,388 | 100,307 | |
| Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 35.00 | 52,925 | 1,852,375 | 0 | 52.9 K to 0 (-100.00 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 1.68 | 27,856 | 46,798 | 52,925 | 25.1 K to 52.9 K (+111.12 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 1.68 | 13,919 | 23,384 | 25,069 | 11.2 K to 25.1 K (+124.83 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 2.39 | 8,165 | 19,514 | 11,150 | 3 K to 11.2 K (+273.53 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 2,985 | 2,388 | 2,985 | 0 to 3 K |
| Mar 29 2019 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 32.49 | 26,400 | 857,736 | 114,584 | 141 K to 114.6 K (-18.73 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 33.36 | 31,422 | 1,048,238 | 668,840 | 700.3 K to 668.8 K (-4.49 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 26.70 | 2,000 | 53,400 | 15,725 | 17.7 K to 15.7 K (-11.28 %) |
| Mar 29 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 33.63 | 14,000 | 470,820 | 165,511 | 179.5 K to 165.5 K (-7.80 %) |
| Mar 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 4,000 | 3,200 | 34,000 | |
| Mar 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.80 | 4,000 | 95,200 | 85,444 | 89.4 K to 85.4 K (-4.47 %) |
| Mar 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.84 | 4,000 | 95,360 | 85,444 | 89.4 K to 85.4 K (-4.47 %) |
| Mar 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.85 | 4,000 | 95,400 | 39,436 | 43.4 K to 39.4 K (-9.21 %) |
| Mar 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 4,000 | 3,200 | 43,436 | 39.4 K to 43.4 K (+10.14 %) |
| Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 1,729 | 1,383 | 8,062 | |
| Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 771 | 617 | 9,791 | |
| Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 25.02 | 1,729 | 43,260 | 0 | 1.7 K to 0 (-100.00 %) |
| Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 1,729 | 1,383 | 1,729 | 0 to 1.7 K |
| Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 25.02 | 771 | 19,290 | 0 | 771 to 0 (-100.00 %) |
| Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 771 | 617 | 771 | 0 to 771 |
| Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 14,681 | 11,745 | 103,292 | |
| Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 1,825 | 1,460 | 117,973 | |
| Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.23 | 14,681 | 370,402 | 0 | 14.7 K to 0 (-100.00 %) |
| Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 14,681 | 11,745 | 14,681 | 0 to 14.7 K |
| Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.02 | 1,825 | 45,662 | 0 | 1.8 K to 0 (-100.00 %) |
| Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 1,825 | 1,460 | 1,825 | 0 to 1.8 K |
| Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 2,000 | 1,600 | 10,562 | |
| Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 2,000 | 1,600 | 10,562 | |
| Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 25.00 | 2,000 | 50,000 | 0 | 2 K to 0 (-100.00 %) |
| Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 25.00 | 2,000 | 50,000 | 0 | 2 K to 0 (-100.00 %) |
| Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 2,000 | 1,600 | 2,000 | 0 to 2 K |
| Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 2,000 | 1,600 | 2,000 | 0 to 2 K |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 1,508 | 1,206 | 119,798 | |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 1,508 | 1,206 | 119,798 | |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 11,986 | 9,589 | 121,306 | |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 11,986 | 9,589 | 121,306 | |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.02 | 1,508 | 37,730 | 0 | 1.5 K to 0 (-100.00 %) |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.02 | 1,508 | 37,730 | 0 | 1.5 K to 0 (-100.00 %) |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 1,508 | 1,206 | 1,508 | 0 to 1.5 K |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 1,508 | 1,206 | 1,508 | 0 to 1.5 K |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.01 | 11,986 | 299,770 | 0 | 12 K to 0 (-100.00 %) |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.01 | 11,986 | 299,770 | 0 | 12 K to 0 (-100.00 %) |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 11,986 | 9,589 | 11,986 | 0 to 12 K |
| Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 11,986 | 9,589 | 11,986 | 0 to 12 K |
| Mar 01 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 23.04 | 2,000 | 46,080 | 17,725 | 19.7 K to 17.7 K (-10.14 %) |
| Feb 27 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 4,000 | 3,200 | 38,000 | |
| Feb 27 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 22.59 | 4,000 | 90,360 | 89,444 | 93.4 K to 89.4 K (-4.28 %) |
| Feb 27 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 22.60 | 4,000 | 90,400 | 89,444 | 93.4 K to 89.4 K (-4.28 %) |
| Feb 27 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 22.60 | 4,000 | 90,400 | 39,436 | 43.4 K to 39.4 K (-9.21 %) |
| Feb 27 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 4,000 | 3,200 | 43,436 | 39.4 K to 43.4 K (+10.14 %) |
| Feb 22 2019 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Option Exercise | A | 22.82 | 60,000 | 1,369,200 | 60,000 | |
| Feb 22 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | A | 22.82 | 100,000 | 2,282,000 | 100,000 | |
| Feb 22 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | A | 22.82 | 30,000 | 684,600 | 30,000 | |
| Feb 22 2019 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Option Exercise | A | 22.82 | 60,000 | 1,369,200 | 60,000 | |
| Feb 22 2019 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Option Exercise | A | 22.82 | 450,000 | 10,269,000 | 450,000 | |
| Feb 07 2019 | TCDA | Tricida, Inc. | Isern Brian M. | 10% Owner | Sell | J | 0.00 | 245,312 | 0 | 0 | 245.3 K to 0 (-100.00 %) |
| Feb 07 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | J | 0.00 | 245,312 | 0 | 0 | 245.3 K to 0 (-100.00 %) |
| Feb 07 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | J | 0.00 | 245,312 | 0 | 0 | 245.3 K to 0 (-100.00 %) |
| Feb 01 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 20.10 | 28 | 563 | 19,725 | 19.8 K to 19.7 K (-0.14 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | Cantrell Susannah | Sr. VP, Chief Comm. ... | Option Exercise | A | 20.05 | 210,000 | 4,210,500 | 210,000 | |
| Jan 30 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 2,000 | 1,600 | 42,000 | |
| Jan 30 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 20.33 | 2,000 | 40,660 | 93,444 | 95.4 K to 93.4 K (-2.10 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 20.32 | 2,000 | 40,640 | 93,444 | 95.4 K to 93.4 K (-2.10 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 20.29 | 2,000 | 40,580 | 39,436 | 41.4 K to 39.4 K (-4.83 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 2,000 | 1,600 | 41,436 | 39.4 K to 41.4 K (+5.07 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 20.09 | 972 | 19,527 | 19,753 | 20.7 K to 19.8 K (-4.69 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 20.35 | 1,000 | 20,350 | 20,725 | 21.7 K to 20.7 K (-4.60 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | Cantrell Susannah | Sr. VP, Chief Comm. ... | Option Exercise | A | 20.05 | 210,000 | 4,210,500 | 210,000 | |
| Jan 30 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 2,000 | 1,600 | 42,000 | |
| Jan 30 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 20.33 | 2,000 | 40,660 | 93,444 | 95.4 K to 93.4 K (-2.10 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 20.32 | 2,000 | 40,640 | 93,444 | 95.4 K to 93.4 K (-2.10 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 20.29 | 2,000 | 40,580 | 39,436 | 41.4 K to 39.4 K (-4.83 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 2,000 | 1,600 | 41,436 | 39.4 K to 41.4 K (+5.07 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 20.09 | 972 | 19,527 | 19,753 | 20.7 K to 19.8 K (-4.69 %) |
| Jan 30 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 20.35 | 1,000 | 20,350 | 20,725 | 21.7 K to 20.7 K (-4.60 %) |
| Jan 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 2,000 | 1,600 | 44,000 | |
| Jan 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 20.86 | 2,000 | 41,720 | 95,444 | 97.4 K to 95.4 K (-2.05 %) |
| Jan 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 20.88 | 2,000 | 41,760 | 95,444 | 97.4 K to 95.4 K (-2.05 %) |
| Jan 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 20.85 | 2,000 | 41,700 | 39,436 | 41.4 K to 39.4 K (-4.83 %) |
| Jan 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 2,000 | 1,600 | 41,436 | 39.4 K to 41.4 K (+5.07 %) |
| Jan 08 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 23.27 | 665 | 15,475 | 0 | 665 to 0 (-100.00 %) |
| Jan 04 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 23.59 | 684 | 16,136 | 0 | 684 to 0 (-100.00 %) |
| Dec 31 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 997 | 798 | 46,000 | |
| Dec 31 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 997 | 798 | 46,000 | |
| Dec 31 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.74 | 740 | 17,568 | 97,444 | 98.2 K to 97.4 K (-0.75 %) |
| Dec 31 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.74 | 740 | 17,568 | 97,444 | 98.2 K to 97.4 K (-0.75 %) |
| Dec 31 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.78 | 700 | 16,646 | 97,444 | 98.1 K to 97.4 K (-0.71 %) |
| Dec 31 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.78 | 700 | 16,646 | 97,444 | 98.1 K to 97.4 K (-0.71 %) |
| Dec 31 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.63 | 997 | 23,559 | 39,436 | 40.4 K to 39.4 K (-2.47 %) |
| Dec 31 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.63 | 997 | 23,559 | 39,436 | 40.4 K to 39.4 K (-2.47 %) |
| Dec 31 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 997 | 798 | 40,433 | 39.4 K to 40.4 K (+2.53 %) |
| Dec 31 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 997 | 798 | 40,433 | 39.4 K to 40.4 K (+2.53 %) |
| Dec 28 2018 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 25.02 | 2,000 | 50,040 | 144,984 | 147 K to 145 K (-1.36 %) |
| Dec 28 2018 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 25.02 | 2,000 | 50,040 | 703,488 | 705.5 K to 703.5 K (-0.28 %) |
| Dec 28 2018 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 25.08 | 3,400 | 85,272 | 21,725 | 25.1 K to 21.7 K (-13.53 %) |
| Dec 28 2018 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 3,254 | 2,603 | 46,997 |